Logo

Ingenium Closes 13.8 Million Round of VC Financing

Dec 11, 2003

NEW YORK, Dec. 11 (GenomeWeb News) - Ingenium Pharmaceuticals has raised €13.8 million ($16.8 million) in a third round of private-equity financing, the company said today.

 

New investor HBM BioVentures and prior Ingenium investors TVM Techno Venture Management and Polaris Venture Partners led the round. Pitching in were Ascenion, Index Ventures, IKB, Schroder Ventures Life Sciences, and Sofinnova Partners.

Breaking News
The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.